<VariationArchive VariationID="981438" VariationName="NM_000891.3(KCNJ2):c.939_944del (p.Ser314_Tyr315del)" VariationType="Deletion" Accession="VCV000981438" Version="10" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2013-04-04" MostRecentSubmission="2024-05-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="969522" VariationID="981438">
      <GeneList>
        <Gene Symbol="KCNJ2" FullName="potassium inwardly rectifying channel subfamily J member 2" GeneID="3759" HGNC_ID="HGNC:6263" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70169532" stop="70180044" display_start="70169532" display_stop="70180044" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68165675" stop="68176184" display_start="68165675" display_stop="68176184" Strand="+" />
          </Location>
          <OMIM>600681</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000891.3(KCNJ2):c.939_944del (p.Ser314_Tyr315del)</Name>
      <CanonicalSPDI>NC_000017.11:70175977:CTCTTA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="70175978" stop="70175983" display_start="70175978" display_stop="70175983" variantLength="6" positionVCF="70175977" referenceAlleleVCF="GCTCTTA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="68172119" stop="68172124" display_start="68172119" display_stop="68172124" variantLength="6" positionVCF="68172118" referenceAlleleVCF="GCTCTTA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.68172119_68172124del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.68172119_68172124del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.70175978_70175983del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.70175978_70175983del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008798.1" sequenceAccession="NG_008798" sequenceVersion="1" change="g.11444_11449del">
            <Expression>NG_008798.1:g.11444_11449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000891.3" sequenceAccession="NM_000891" sequenceVersion="3" change="c.939_944del" MANESelect="true">
            <Expression>NM_000891.3:c.939_944del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000882.1" sequenceAccession="NP_000882" sequenceVersion="1" change="p.Ser314_Tyr315del">
            <Expression>NP_000882.1:p.Ser314_Tyr315del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_328" sequenceAccession="LRG_328">
            <Expression>LRG_328:g.11444_11449del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_328t1" sequenceAccession="LRG_328t1">
            <Expression>LRG_328t1:c.939_944del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600681.0005" DB="OMIM" />
        <XRef Type="rs" ID="2074390325" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000891.3(KCNJ2):c.939_944del (p.Ser314_Tyr315del) AND Andersen Tawil syndrome" Accession="RCV001260872" Version="5">
        <ClassifiedConditionList TraitSetID="2458">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-05-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000891.3(KCNJ2):c.939_944del (p.Ser314_Tyr315del) AND multiple conditions" Accession="RCV001379609" Version="6">
        <ClassifiedConditionList TraitSetID="9142">
          <ClassifiedCondition DB="MedGen" ID="C1563715">Andersen Tawil syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865018">Short QT syndrome type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-09-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-09-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-05-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11371347</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12163457</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12909315</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14522976</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22002906</ID>
        </Citation>
        <DescriptionHistory Dated="2022-07-28">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
            <Trait ID="3722" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 3</ElementValue>
                <XRef ID="MONDO:0012314" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT3</ElementValue>
                <XRef Type="MIM" ID="609622" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18635" />
                <XRef ID="18635" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865018" DB="MedGen" />
              <XRef ID="MONDO:0012314" DB="MONDO" />
              <XRef Type="MIM" ID="609622" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2458" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="244" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Andersen Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Andersen Tawil syndrome</ElementValue>
                <XRef ID="Andersen+Tawil+Syndrome/431" DB="Genetic Alliance" />
                <XRef ID="422348008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen cardiodysrhythmic periodic paralysis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Long QT syndrome 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Periodic paralysis, potassium-sensitive cardiodysrhythmic type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">LQT7</ElementValue>
                <XRef Type="MIM" ID="170390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9453" />
                <XRef ID="9453" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Andersen-Tawil syndrome (ATS) is characterized by a triad of: episodic flaccid muscle weakness (i.e., periodic paralysis); ventricular arrhythmias and prolonged QT interval; and anomalies including low-set ears, widely spaced eyes, small mandible, fifth-digit clinodactyly, syndactyly, short stature, and scoliosis. Affected individuals present in the first or second decade with either cardiac symptoms (palpitations and/or syncope) or weakness that occurs spontaneously following prolonged rest or following rest after exertion. Mild permanent weakness is common. Mild learning difficulties and a distinct neurocognitive phenotype (i.e., deficits in executive function and abstract reasoning) have been described.</Attribute>
                <XRef ID="NBK1264" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301441</ID>
                <ID Source="BookShelf">NBK1264</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="37553" DB="Orphanet" />
              <XRef ID="C1563715" DB="MedGen" />
              <XRef ID="MONDO:0008222" DB="MONDO" />
              <XRef Type="MIM" ID="170390" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3103036" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="7887362|MedGen:C1865018;C1563715" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001577440" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV001437968" DateChanged="2023-04-03" Version="1">
            <Comment Type="MergeComment">SCV001437968 was merged into SCV001577440 because sCV001437968 was merged into SCV001577440 to remove duplication</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2020-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11371347</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12163457</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12909315</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12163457</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22002906</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14522976</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant, c.939_944del, results in the deletion of 2 amino acid(s) of the KCNJ2 protein (p.Ser314_Tyr315del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). Deletion of these amino acids has been observed in individual(s) with Andersen-Tawil syndrome (PMID: 11371347, 12163457, Invitae). In at least one individual the variant was observed to be de novo. Experimental studies have shown that this deletion affects KCNJ2 protein function (PMID: 12909315, 12163457, 22002906, 14522976).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNJ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.68172119_68172124del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865018" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1563715" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="29695" SubmissionDate="2012-09-26" DateLastUpdated="2024-05-07" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600681.0005_ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" title="KCNJ2, 6-BP DEL, NT1167_ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" />
        <ClinVarAccession Accession="SCV000029695" DateUpdated="2024-05-07" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-05-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an affected individual of a pedigree (K5768) with Andersen syndrome (170390), Plaster et al. (2001) identified a heterozygous (dominant) in-frame deletion of 6 nucleotides in the KCNJ2 gene, resulting in the deletion of amino acids 314 to 315. This mutation occurred de novo in this family and was not found in 100 unaffected and unrelated individuals.</Attribute>
              <Citation>
                <ID Source="PubMed">11371347</ID>
              </Citation>
              <XRef DB="OMIM" ID="170390" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNJ2" />
          </GeneList>
          <Name>KCNJ2, 6-BP DEL, NT1167</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, NT1167</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600681.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29695" TraitType="Disease" MappingType="Name" MappingValue="ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS" MappingRef="Preferred">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3103036" TraitType="Disease" MappingType="XRef" MappingValue="C1563715" MappingRef="MedGen">
        <MedGen CUI="C1563715" Name="Andersen Tawil syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3103036" TraitType="Disease" MappingType="XRef" MappingValue="C1865018" MappingRef="MedGen">
        <MedGen CUI="C1865018" Name="Short QT syndrome type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

